| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/29/2011 | US20110238180 Cartilage replacement implant and method for producing a cartilage replacement implant |
| 09/29/2011 | US20110237779 Cdr-repaired antibodies |
| 09/29/2011 | US20110237676 Spermicidal and microbicidal compositions |
| 09/29/2011 | US20110237655 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 09/29/2011 | US20110237654 Method to inhibit cell growth using oligonucleotides |
| 09/29/2011 | US20110237651 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo |
| 09/29/2011 | US20110237650 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf |
| 09/29/2011 | US20110237649 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1 |
| 09/29/2011 | US20110237647 Inhibitory rna for modulating the molecular function of zfat gene |
| 09/29/2011 | US20110237645 USE OF RNAi TECHNOLOGY TO INHIBIT ASIC3 |
| 09/29/2011 | US20110237644 Ubiquitin specific proteases responsible for mcl-1 stability and uses thereof |
| 09/29/2011 | US20110237643 Identification of a Novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity |
| 09/29/2011 | US20110237574 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 09/29/2011 | US20110237573 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators |
| 09/29/2011 | US20110237559 6-SUBSTITUTED SULFONYL AZABICYCLO[3.2.1]OCTANES USEFUL TO INHIBIT 11Beta-HYDROXYSTEROID DEHYDROGENASE TYPE-1 |
| 09/29/2011 | US20110237529 Adenosine Analogs and Their Use |
| 09/29/2011 | US20110237528 Compositions and methods comprising imidazole and triazole derivatives |
| 09/29/2011 | US20110237522 Neutral nanotransporters |
| 09/29/2011 | US20110237521 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 09/29/2011 | US20110237519 Hematopoietic Growth Factor Inducible Neurokinin-1 Gene and Uses Thereof |
| 09/29/2011 | US20110237517 Iap inhibitors |
| 09/29/2011 | US20110237515 Peptide derived from neurotesin receptor 3 and use thereof in the treatment of psychiatric diseases |
| 09/29/2011 | US20110237498 Soluble polypeptides for use in treating autoimmune and inflammatory disorders |
| 09/29/2011 | US20110237497 Compositions of a v-atpase inhibitor in combination with a glucocorticoid receptor ligand and methods of use |
| 09/29/2011 | US20110237496 Antinecrotic activity of alpha 1-antitrypsin |
| 09/29/2011 | US20110237485 Chrysosporium Cellulase and Methods of Use |
| 09/29/2011 | US20110237448 Carbohydrate binding module with affinity for insoluble xylan |
| 09/29/2011 | US20110237435 Lipophilic nucleic acid delivery vehicle and methods of use thereof |
| 09/29/2011 | US20110236977 Dental stem cell differentiation |
| 09/29/2011 | US20110236975 Growth factor which acts through erb b-4 rtk |
| 09/29/2011 | US20110236974 Compositions and methods for making and using laminin nanofibers |
| 09/29/2011 | US20110236973 Centrosome proteins and uses thereof |
| 09/29/2011 | US20110236972 Nucleic acid compounds for inhibiting birc5 gene expression and uses thereof |
| 09/29/2011 | US20110236971 Generation of Clonal Mesenchymal Progenitors and Mesenchymal Stem Cell Lines Under Serum-Free Conditions |
| 09/29/2011 | US20110236970 Chamber of a bioreactor platform |
| 09/29/2011 | US20110236969 Methods of generating variant proteins with increased host string content and compositions thereof |
| 09/29/2011 | US20110236968 Humanized antibodies against monocyte chemotactic proteins |
| 09/29/2011 | US20110236967 Promiscuous her-2/neu cd4 t cell epitopes |
| 09/29/2011 | US20110236966 Single lentiviral vector system for induced pluripotent (ips) stem cells derivation |
| 09/29/2011 | US20110236957 Nanoparticle Labeling Reagents and Methods of Use |
| 09/29/2011 | US20110236956 MULTICISTRONIC siRNA CONSTRUCTS TO INHIBIT TUMORS |
| 09/29/2011 | US20110236953 EMBRYONIC CEREBROSPINAL FLUID (e-CSF), PROTEINS FROM e-CSF, AND RELATED METHODS AND COMPOSITIONS |
| 09/29/2011 | US20110236930 Chemoselective ligation |
| 09/29/2011 | US20110236922 Method to determine state of a cell exchanging metabolites with a fluid medium by analyzing the metabolites in the fluid medium |
| 09/29/2011 | US20110236904 Detection of tumor stem cells and tumor cells in epithelial-mesenchymal transition in body fluids of cancer patients |
| 09/29/2011 | US20110236900 Novel muts protein and method for determing mutation using the same |
| 09/29/2011 | US20110236894 Selective oxidation of 5-methylcytosine by tet-family proteins |
| 09/29/2011 | US20110236874 Method for formation of renal tubules |
| 09/29/2011 | US20110236469 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/29/2011 | US20110236464 Membrane |
| 09/29/2011 | US20110236455 Novel Regulators of the Innate Immune System |
| 09/29/2011 | US20110236437 Nanoparticles and methods of use |
| 09/29/2011 | US20110236435 ENHANCED BONE CELLS GROWTH AND PROLIFERATION ON TiO2 NANOTUBULAR SUBSTRATES TREATED BY RADIO-FREQUENCY PLASMA DISCHARGE |
| 09/29/2011 | US20110236429 Small Cationic Antimicrobial Peptides |
| 09/29/2011 | US20110236416 Foot and mouth disease virus recombinant vaccines and uses thereof |
| 09/29/2011 | US20110236411 MHC Multimers in Tuberculosis Diagnostics, Vaccine and Therapeutics |
| 09/29/2011 | US20110236410 Klebsiella antigens |
| 09/29/2011 | US20110236409 Overlapping peptides from variable antigens, t cell populations and uses thereof |
| 09/29/2011 | US20110236406 Immunogenic compositions comprising hmgb1 polypeptides |
| 09/29/2011 | US20110236404 Methods for Protein Expression in Mammalian Cells in Serum-Free Medium |
| 09/29/2011 | US20110236394 Methods for the regulation of the prostaglandin f synthase (pgfs) activity of akr1b1 and uses thereof |
| 09/29/2011 | US20110236393 Monoclonal antibody production in b cells and uses therof |
| 09/29/2011 | US20110236390 IL-17A Antagonists |
| 09/29/2011 | US20110236389 Human Angiostatin Interacting and Tumor Metastasis Involving Protein Variants and Uses Thereof |
| 09/29/2011 | US20110236388 Bispecific, bivalent anti-vegf/anti-ang-2 antibodies |
| 09/29/2011 | US20110236385 Blocking mesothelin peptide fragments |
| 09/29/2011 | US20110236380 Ligands that bind il-13 |
| 09/29/2011 | US20110236378 Non-human mammals for the production of chimeric antibodies |
| 09/29/2011 | US20110236377 Hepatocyte Growth Factor (HGF) Binding Proteins |
| 09/29/2011 | US20110236375 Antibody variants with enhanced complement activity |
| 09/29/2011 | US20110236374 Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2 |
| 09/29/2011 | US20110236366 Production and uses of type i ribosome inactivating proteins |
| 09/29/2011 | US20110236363 System and method for producing t cells |
| 09/29/2011 | US20110236362 NKT CELL-DERIVED iPS CELLS AND NKT CELLS DERIVED THEREFROM |
| 09/29/2011 | US20110236356 Methods of isolating and using stem cells |
| 09/29/2011 | US20110236355 Differentiation of stem cells into dopaminergic cells |
| 09/29/2011 | US20110236353 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 09/29/2011 | US20110236348 Modulators of toll-like receptor 7 |
| 09/29/2011 | US20110236347 Monoclonal Anti-Claudin 1 Antibodies for the Inhibition of Hepatitis C Virus Infection |
| 09/29/2011 | US20110236344 Synthetic mimics of mammalian cell surface receptors: method and compositions |
| 09/29/2011 | US20110236309 Antagonists of ligands and uses thereof |
| 09/29/2011 | US20110236306 Compositions and methods for the removal of biofilms |
| 09/29/2011 | US20110232179 Grg23 epsp synthases: compositions and methods of use |
| 09/29/2011 | CA2831271A1 The isolation and use of fad2 and fae1 from camelina |
| 09/29/2011 | CA2794359A1 Infectious hepatitis c virus-high producing hcv variants and use thereof |
| 09/29/2011 | CA2794167A1 Bmp-7 peptides & methods of use |
| 09/29/2011 | CA2794165A1 Bmp-4 peptides & methods of use |
| 09/29/2011 | CA2793971A1 Culture method for causing differentiation of pluripotent mammalian cells |
| 09/29/2011 | CA2793753A1 Antibodies to muc16 and methods of use thereof |
| 09/29/2011 | CA2793216A1 Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomics |
| 09/28/2011 | EP2369517A2 Methods for the identification of microrna and their applications in research and human health |
| 09/28/2011 | EP2369005A1 Biological active proteins having increased in vivo and/or in vitro stability |
| 09/28/2011 | EP2369002A1 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| 09/28/2011 | EP2368999A1 Bone targeted alkaline phosphatase, kits and methods of use thereof |
| 09/28/2011 | EP2368987A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same |
| 09/28/2011 | EP2368986A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 09/28/2011 | EP2368977A1 Mutant luciferase having increased thermostability |
| 09/28/2011 | EP2368976A1 Mutant luciferase having increased thermostability |
| 09/28/2011 | EP2368975A1 Non-tumorigenic MDCK cell line for propagating viruses |
| 09/28/2011 | EP2368974A1 Methods for isolating mesenchymal stem cells from embryos of human or animals and extracting secretion substances thereof |